mstockstill on DSK4VPTVN1PROD with NOTICES


32642 Federal Register / Vol. 77, No. 106 / Friday, June 1, 2012 / Notices 

agents, whether naturally occurring, 

accidental, or deliberate. The Board may 

also provide advice and guidance to the 

Secretary and/or the Assistant Secretary 

for Preparedness and Response (ASPR) 

on other matters related to public health 

emergency preparedness and response. 

Background: The June 26, 2012, 

public meeting will be dedicated to the 

introduction of two new tasks to the 

NBSB. The NBSB is being tasked to 

advise the HHS Secretary on the 

development of a national public health 

and healthcare situational awareness 

strategy and implementation plan. In 

addition, the NBSB, in collaboration 

with the Public Health Preparedness 

and Response—Board of Scientific 

Counselors, a Centers for Disease 

Control and Prevention Federal 

Advisory Committee, is being tasked 

with identification and evaluation of the 

anticipated responsibilities of the 

Strategic National Stockpile for the year 

2020. The NBSB continues to review 

and evaluate the 2012 Public Health 

Emergency Medical Countermeasures 

Enterprise (PHEMCE) Strategy and 

Implementation Plan (SIP). Therefore, 

the Board’s deliberations on the 

PHEMCE SIP task are being conducted 

in closed sessions in accordance with 

provisions set forth under exemption 

9(B) of the Government in Sunshine 

Act, 5 U.S.C. 552b(c), and with approval 

by the ASPR. For a full description for 

the basis for closing the meeting on June 

25, 2012, please see the previous 

meeting notice published at 77 FR 

13129 (2012). 

Availability of Materials: The meeting 

agenda and materials will be posted on 

the NBSB Web site at www.PHE.GOV/ 

NBSB prior to the meeting. 

Procedures for Providing Public Input: 

Any member of the public providing 

oral comments at the meeting must signin at the registration desk and provide 

his/her name, address, and affiliation. 

All written comments must be received 

prior to June 21, 2012, and should be 

sent by email to NBSB@HHS.GOV with 

‘‘NBSB Public Comment’’ as the subject 

line. Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

email NBSB@HHS.GOV. 

Dated: May 25, 2012. 

Nicole Lurie, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2012–13387 Filed 5–31–12; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Determination Concerning a Petition 

To Add a Class of Employees to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

determination concerning a petition to 

add a class of employees from Hangar 

481 at Kirtland Air Force Base to the 

Special Exposure Cohort (SEC) under 

the Energy Employees Occupational 

Illness Compensation Program Act of 

2000 (EEOICPA), 42 U.S.C. 7384q. On 

May 11, 2012, the Secretary of HHS 

determined that the following class of 

employees does not meet the statutory 

criteria for addition to the SEC as 

authorized under EEOICPA: 

All employees who worked at Hangar 481, 

Kirtland Air Force Base, from March 1, 1989 

through February 29, 1996. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 

1–877–222–7570. Information requests 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–13378 Filed 5–31–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Patents and Inventions; Delegation of 

Authority 

Notice is hereby given that I have 

delegated to the Director, Division of 

Laboratory Policy and Practice (DLPP), 

Laboratory Science Policy and Practice 

Program Office (LSPPPO), Office of 

Surveillance, Epidemiology and 

Laboratory Services (OSELS), Centers 

for Disease Control and Prevention 

(CDC), the Deputy Director, DLPP, 

LSPPPO, OSELS, CDC, and the Chief, 

Technology Management Branch, DLPP, 

LSPPPO, OSELS, without authority to 

redelegate, all authorities to administer 

and make decisions regarding the 

invention and patent program of CDC 

and the authority to make 

determinations of rights in inventions 

and patents in which CDC and the 

Department have an interest. 

This delegation excludes the authority 

under 35 U.S.C. 203 (March-in Rights) 

and the authority to submit reports to 

Congress. 

In addition, this delegation excludes 

those authorities under the StevensonWydler Technology Act of 1980, as 

amended by the Federal Technology 

Transfer Act of 1986 and the National 

Technology Transfer and Advancement 

Act of 1995, which are governed by a 

separate delegation. 

The exercise of this authority must be 

in accordance with applicable laws, 

regulations, and Office of Government 

Ethics, U.S. Office of Personnel 

Management, and DHHS policies and 

instructions. 

This delegation became effective upon 

date of signature. I hereby affirm and 

ratify any actions taken that involve the 

exercise of the authorities delegated 

herein prior to the effective date of this 

delegation. 

Dated: May 14, 2012. 

Thomas R. Frieden, 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–13238 Filed 5–31–12; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–P–0804] 

Medical Devices; Exemption From 

Premarket Notification: Powered 

Patient Transport 

AGENCY: Food and Drug Administration, 


HHS. 


ACTION: Notice. 


SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that it has received a petition requesting 

exemption from the premarket 

notification requirements for powered 

patient transport devices commonly 

known as stairlifts. These devices are 

used to assist transfers of a mobility 

impaired person up and down flights of 

stairs. FDA is publishing this notice to 

obtain comments in accordance with 

procedures established by the Food and 

Drug Administration Modernization Act 

of 1997 (FDAMA). 

DATES: Submit either electronic or 

written comments by July 2, 2012.